Aino Health AB shares climbed sharply, rising 51.6% to SEK 0.194, after a consortium led by Finnish investors disclosed a public tender offer to buy the remaining shares in the Stockholm-listed corporate health management company for SEK 0.20 in cash per share.
The offer price equates to a premium of roughly 56% relative to Monday's closing price, and places a higher value on the company as a whole. The proposal pegs the market value of Aino Health’s approximately 204.6 million shares outstanding at about SEK 40.91 million. The stake in the company not already held by the consortium is valued at approximately SEK 21.16 million under the terms of the offer.
The acquiring group is made up of eight Finnish entities and individuals, with Nexit III Ky and Tenendum Oy identified as the two largest holders among them. Prior to the tender, the consortium already controlled about 48.27% of Aino Health’s shares and voting rights, making this a consolidation effort to move toward full ownership.
The cash bid also represents a notable uplift versus recent trading averages - about a 58% premium to the 30-day volume-weighted average price (VWAP) and roughly a 53% premium to the 90-day VWAP, which sits around SEK 0.130. Those relative measures highlight the scale of the incentive being offered to minority shareholders to tender their shares.
However, the transaction is conditional. Completion requires the consortium to reach ownership in excess of 90% on a fully diluted basis, in addition to securing all required regulatory approvals. Those conditions are set out as part of the offer and will determine whether the deal can move forward to completion.
The announcement came amid a broadly firmer European trading session. The pan-European STOXX 600 was trading up by about 0.4% in early trade, and the OMX Stockholm 30 opened firmer around 3,171 before moving toward an intraday range near 3,178–3,186. Market participants were also tracking central bank speeches and economic data releases across Europe, though those macro events did not play a meaningful role in the specific move in Aino Health shares.
Taken together, the public tender offer from a clearly identified consortium that already holds a near-majority stake produced a classic M&A-driven re-rating of the stock, driving the share price sharply toward the offer level and explaining the bulk of the day's strong gain.